Manorama Tewari

Title: Manorama Tewari: Innovator in Apoptosis Modulation

Introduction

Manorama Tewari is a distinguished inventor based in East Lansdowne, PA (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of apoptosis. Her innovative work has led to the development of a patent that addresses critical cellular processes.

Latest Patents

Manorama Tewari holds a patent for "Compositions and methods for modulating apoptosis - AAC-11 polypeptide and DNA (RNA) encoding AAC-11 polypeptide and methods for producing such polypeptide by recombinant techniques." This patent outlines methods of using the AAC-11 polynucleotides and/or polypeptides to inhibit apoptosis in cells. Furthermore, it includes methods of using agonists or antagonists to AAC-11 polypeptides to inhibit or induce apoptosis in cells. She has 1 patent to her name.

Career Highlights

Tewari is affiliated with Thomas Jefferson University, where she continues her research and development in the field of apoptosis modulation. Her work is pivotal in understanding how to manipulate cell death, which has implications for various diseases, including cancer.

Collaborations

One of her notable collaborators is Raphael Rubin, with whom she has worked closely on various projects related to her research.

Conclusion

Manorama Tewari's contributions to the field of biotechnology through her innovative patent on apoptosis modulation highlight her role as a leading inventor. Her work not only advances scientific understanding but also opens new avenues for therapeutic interventions.